Clarity Pharmaceuticals Ltd has released a press release.
Positive topline results from SAR-bisPSMA diagnostic trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Clarity Pharmaceuticals
- Managing Directors Presentation to AGM
- Chairmans Address to Shareholders
- IND approval from the FDA for theranostic SAR-Bombesin trial
- Clarity Presentation -Bell Potter Healthcare Conference 2022
- 50% recruitment reached for Phase II prostate cancer trial
Later from Clarity Pharmaceuticals
- Diagnostic prostate cancer trial reaches recruitment target
- PROPELLER Trial Results
- 50% recruitment milestone for NET diagnostic Phase II trial
- Clarity Corporate Presentation
- Clarity Receives $6.7 million R&D Tax Incentive Refund
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals